Daniel Scherman

29.1k total citations · 5 hit papers
418 papers, 24.2k citations indexed

About

Daniel Scherman is a scholar working on Molecular Biology, Genetics and Biomedical Engineering. According to data from OpenAlex, Daniel Scherman has authored 418 papers receiving a total of 24.2k indexed citations (citations by other indexed papers that have themselves been cited), including 260 papers in Molecular Biology, 86 papers in Genetics and 70 papers in Biomedical Engineering. Recurrent topics in Daniel Scherman's work include RNA Interference and Gene Delivery (119 papers), Advanced biosensing and bioanalysis techniques (78 papers) and Virus-based gene therapy research (75 papers). Daniel Scherman is often cited by papers focused on RNA Interference and Gene Delivery (119 papers), Advanced biosensing and bioanalysis techniques (78 papers) and Virus-based gene therapy research (75 papers). Daniel Scherman collaborates with scholars based in France, Belgium and Israel. Daniel Scherman's co-authors include Jean‐Paul Behr, Barbara Demeneix, Otmane Boussif, Frank Lezoualc’h, Michel Bessodes, Cyrille Richard, Johanne Séguin, Thomas Maldiney, Michel F. Bureau and Virginie Escriou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Angewandte Chemie International Edition.

In The Last Decade

Daniel Scherman

414 papers receiving 23.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

1995 5.2k citations Daniel Scherman et al. profile →
The in vivo activation of persistent nanophosphors for optical imaging of vascularization, tumours and grafted cells

2014 956 citations Johanne Séguin, Bruno Viana et al. profile →
High-efficiency gene transfer into skeletal muscle mediated by electric pulses

1999 749 citations Daniel Scherman et al. profile →
Nanoprobes with near-infrared persistent luminescence for in vivo imaging

2007 736 citations Corinne Chanéac, Johanne Séguin et al. profile →
Protective Role of Interleukin-10 in Atherosclerosis

1999 647 citations Daniel Scherman et al. profile →

Peers

Countries citing papers authored by Daniel Scherman

Since Specialization

Citations

This map shows the geographic impact of Daniel Scherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Scherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Scherman more than expected).

Fields of papers citing papers by Daniel Scherman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Scherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Scherman. The network helps show where Daniel Scherman may publish in the future.

Co-authorship network of co-authors of Daniel Scherman

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Scherman. A scholar is included among the top collaborators of Daniel Scherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Scherman. Daniel Scherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chromium‐Doped Zinc Gallate Nanoparticles for Enhanced Enzyme‐Linked Immunosorbent Assay Sensitivity: Optimization of Synthesis and Functionalization Strategies for Ultra‐Low IgG Detection 2025 ·Small Science ·(unknown), Jianhua Liu, (unknown), Corinne Chanéac, Bruno Viana, Cédric Bouzigues, Daniel Scherman, Nathalie Mignet, Cyrille Richard	0
2	In Situ Bioorthogonal Repair of the Vascular Endothelium Glycocalyx to Treat Acute Lung Injury 2024 ·Small ·Yao Wang, (unknown), (unknown), Weidong Li, Anqi Wang, Zhoujiang Chen, Huile Gao, Di Wu, Fang Geng, Daniel Scherman, Xianwen Wang, Sanjun Shi, Liang Zou, Hanmei Li	2
3	The complexity of funding rare disease research: an IRDiRC assessment of the landscape 2024 ·University of Twente Research Information ·Lucía Monaco, (unknown), Naohiko Aketa, (unknown), (unknown), (unknown), Alı́cia Granados, (unknown), Anneliene Hechtelt Jonker, Susan R. Kahn, (unknown), (unknown), (unknown), Christopher McMaster, (unknown), Daniel Scherman, (unknown), (unknown), Adam L. Hartman	3
4	Chromium-doped zinc gallate: Impact of Sn4+ co-doping on the persistent luminescence properties at the nanoscale applied to bio-imaging 2024 ·Chemical Engineering Journal ·(unknown), Johanne Séguin, (unknown), Corinne Chanéac, Yohann Corvis, Daniel Scherman, Nathalie Mignet, Bruno Viana, Cyrille Richard	20
5	Personalized and Precision Medicine (PPM) as a Unique Healthcare Model of the Next Step Generation: The role of a Nurses and Nursing Practice in Transdisciplinary Care Team: The Future of Nursing Services 2024 ·Sergey Suchkov, Daniel Scherman	0
6	Carbopol dispersed PAA-modified UIO-66 with high colloidal stability as a combination nano-adjuvant boosts immune response and protection against pseudorabies virus in mice and pigs 2023 ·Acta Biomaterialia ·Xiaoling Liao, Jingjing Nie, (unknown), Feng Zhao, (unknown), Yang‐Chang Wu, Yuan Li, Daniel Scherman, Yingshuai Liu	7
7	Fate and biological impact of persistent luminescence nanoparticles after injection in mice: a one-year follow-up 2022 ·Nanoscale ·Thomas J. L’Ecuyer, Johanne Séguin, Alice Balfourier, (unknown), Pierre Bürckel, René Lai–Kuen, Virginie Mignon, Bertrand Ducos, (unknown), Bruno Saubaméa, Daniel Scherman, Nathalie Mignet, Florence Gazeau, Cyrille Richard	30
8	Degradation of ZnGa₂O₄:Cr³⁺ luminescent nanoparticles in lysosomal-like medium 2019 ·Nanoscale ·Thomas J. L’Ecuyer, (unknown), Jeanne Volatron, Morgane Desmau, René Lai–Kuen, Yohann Corvis, Johanne Séguin, Guillaume Wang, Damien Alloyeau, Daniel Scherman, Nathalie Mignet, Florence Gazeau, Cyrille Richard	30
9	Small-scale GMP production of plasmid DNA using a simplified and fully disposable production method 2019 ·Journal of Biotechnology ·Noor A. M. Bakker, Renate de Boer, Corinne Marie, Daniel Scherman, John B.A.G. Haanen, Jos H. Beijnen, Bastiaan Nuijen, Joost H. van den Berg	13
10	Development of GMP-compliant production of freshly isolated and transfected iris pigment epithelial (IPE) cells to treat age-related macular degeneration (AMD) 2017 ·Martina Kropp, Gabriele Thumann, (unknown), (unknown), (unknown), Jaap van den Berg, Corinne Marie, Sandra Johnen, Zsuzsanna Izsvák, (unknown), Daniel Scherman	2
11	Diagnostic criteria in amyotrophic lateral sclerosis 2016 ·Neurology ·Nimeshan Geevasinga, Parvathi Menon, Daniel Scherman, Neil G. Simon, Con Yiannikas, Robert D. Henderson, Matthew C. Kiernan, Steve Vucic	36
12	Optical properties and storage capabilities of AB 2 O 4 :Cr 3+ (A=Zn,Mg,B=Ga,Al) 2014 ·Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE ·Surender Kumar Sharma, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Daniel Scherman, (unknown)	1
13	Synthesis and in vitro evaluation of potential anticancer activity of mono- and bis-1,2,3-triazole derivatives of bis-alkynes 2012 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Guy G. Chabot, Lionel Quentin, Daniel Scherman, Christian Girard	67
14	The NTS-DBL2X Region of VAR2CSA Induces Cross-Reactive Antibodies That Inhibit Adhesion of Several Plasmodium falciparum Isolates to Chondroitin Sulfate A 2011 ·The Journal of Infectious Diseases ·Pascal Bigey, Sédami Gnidehou, Justin Doritchamou, (unknown), Firmine Viwami, Aude Couturier, Ali Salanti, Morten A. Nielsen, Daniel Scherman, Philippe Deloron, Nicaise Tuikue Ndam	50
15	Ear Pinna: A Privileged DNA Electroporation Site for Inducing Strong Th1 Immune Responses 2009 ·Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) ·Jing Ni, (unknown), Gaëlle Vandermeulen, Véronique Préat, Daniel Scherman, Volker Schirrmacher, Philippe Fournier	4
16	169 FORMULATION AND EVALUATION OF ATP-CONTAINING LIPOSOMES INCLUDING LACTOSYLATED ASGPR LIGAND TO ENHANCE CELLULAR ENERGY STATUS FOR HEPATIC APPLICATIONS 2009 ·Journal of Hepatology ·(unknown), (unknown), (unknown), Cyrille Richard, Virginie Escriou, Céline Largeau, Daniel Scherman, Luc Cynober, J.C. Chaumeil, G. Dumortier	1
17	CD36 Deficiency Leads to Choroidal Involution via COX2 Down-Regulation in Rodents 2008 ·PLoS Medicine ·Marianne Houssier, William Raoul, Sophie Lavalette, Nicole Keller, Xavier Guillonneau, Barbara Baragatti, Laurent Jonet, Jean‐Claude Jeanny, Francine Béhar‐Cohen, Flavio Coceani, Daniel Scherman, Pierre Lachapelle, Huy Ong, Sylvain Chemtob, Florian Sennlaub	67
18	Reducible cationic lipids for gene transfer 2001 ·Biochemical Journal ·Barbara Wetzer, Gérardo Byk, (unknown), (unknown), Francis Blanche, (unknown), Daniel Scherman	56
19	Biology and physiology of the blood-brain barrier : transport, cellular interactions, and brain pathologies 1996 ·Plenum Press eBooks ·Pierre‐Olivier Couraud, Daniel Scherman	7
20	[Effect of transmembrane potential on noradrenaline transport in chromaffin granules]. 1979 ·Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·Daniel Scherman, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact